NYSE:HQL

Tekla Life Sciences Investors Stock News

etoro logo Buy HQL
*Your capital is at risk
$18.63
+0.290 (+1.58%)
At Close: Jun 23, 2026
I maintain a buy rating on abrdn Life Sciences Investors Fund (HQL), which trades at an 8.49% discount to NAV and offers a 12.6% yield. HQL is positioned to benefit from the accelerating GLP-1 market,
PHILADELPHIA, May 11, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, THW and NYSE American: FAX, IAF, VFL), announce
The market environment is challenging, to say the least. We discuss how one should invest in today's market. The article presents five different investment strategies, including a fixed-income strateg
PHILADELPHIA, March 31, 2026 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE: ASGI, HQH, HQL, IFN, THQ), (NYSE American: IAF) (the "Funds" or individually the "Fund"), today anno
The article presents a rigorously screened list of 10 top closed-end funds, or CEFs, for income investors, offering an average 10% plus yield and 10.8% NAV discount. Selections emphasize sector divers
The article presents a rigorously screened list of 10 top closed-end funds, or CEFs, for income investors, offering an average 9.7% yield and -10% NAV discount. Selections emphasize sector diversifica
PHILADELPHIA, Feb. 10, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, THW and NYSE American: FAX, FCO, IAF, VFL), an
If you're wondering whether the rally in tech stocks is fading, well, it is.

HQL: Dividend Can Be Sustained Through 2026

02:38am, Wednesday, 28'th Jan 2026
abrdn Life Sciences Investors Fund maintains a buy rating, offering a compelling 11.6% yield and trading at a 9.58% NAV discount. HQL's income-focused strategy relies on net realized gains, supporting
PHILADELPHIA, Jan. 12, 2026 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE: ASGI, HQH, HQL, IFN, THQ), (NYSE American: IAF), (the "Funds" or individually the "Fund"), today annou
abrdn Life Sciences Investors (NYSE: HQL - Get Free Report) saw a large drop in short interest in the month of December. As of December 15th, there was short interest totaling 54,047 shares, a drop of
PHILADELPHIA , Nov. 11, 2025 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, THW and NYSE American: FAX, FCO, IAF, VFL), a
abrdn Life Sciences Investors remains a buy for high-yield seekers, offering a 10.1% dividend yield and diversified healthcare exposure. HQL trades at a 7.92% discount to NAV, with its share price his
PHILADELPHIA , Sept. 30, 2025 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE: ASGI, HQH, HQL, IFN, THQ), (NYSE American: IAF)  (the "Funds" or individually the "Fund"), today a
HQL offers a high 12% yield and trades at a discount, making it attractive for income-focused investors seeking healthcare sector exposure. The fund is heavily weighted in biotechnology, leading to un
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE